INmune Bio
INMB
INMB
35 hedge funds and large institutions have $11.7M invested in INmune Bio in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 34 → 35 (+1)
0.89% more ownership
Funds ownership: 9.18% → 10.07% (+0.89%)
Holders
35
Holding in Top 10
–
Calls
$175K
Puts
$14K
Top Buyers
| 1 | +$483K | |
| 2 | +$454K | |
| 3 | +$280K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$158K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$120K |
Top Sellers
| 1 | -$156K | |
| 2 | -$147K | |
| 3 | -$34K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.7K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$17.3K |